Результаты поиска

Longitudinal Collection of Patient-Reported Outcomes and Activity Data during CAR-T Therapy: Feasibility, Acceptability, and Data Visualization.

Background: Clinicians must closely monitor patients for toxicities after chimeric antigen receptor T-cell therapy (CAR-T). Patient-reported outcomes (PROs) (e.g., toxicities, quality of life) and activity data (e.g., steps, sleep) may complement clinicians’ observations. This study tested the feasibility and acceptability of collecting PROs and activity data from patients with hematologic malignancies during CAR-T and explored preliminary data patterns. Methods: Participants wore a Fitbit tracker and completed PROs at several timepoints through 90-days post-infusion. Feasibility was assessed

Совпадение в полном тексте источника
… Funding Statement This work was supported in part by a 2020 Moffitt Cancer Center Team Science Award (MPIs: Oswald, Kirtane), Moffitt Cancer Center’s Participant Research, Interventions, and Measurement (PRISM) Core and Biostatistics and Bioinformatics Shared Resource (BBSR), and an NIH/NCI Cancer Center …

Nursing Procedures for the Prevention and Treatment of Mucositis Induced by Cancer Therapies: Clinical Practice Guideline Based on an Interdisciplinary Consensus Process and a Systematic Literature Search.

BackgroundPatients with cancer receiving tumor therapy often suffer from oral mucositis.ObjectivesThe aim of this project was to summarize experiences with nursing procedures by experts in integrative oncology and to establish recommendations for nursing interventions that can prevent or cure mucositis.MethodsThe study design was an interdisciplinary consensus process based on a systematic literature search.ResultsThe panel discussed and agreed on 19 nursing procedures, which included mouthwashes, such as teas, supplements, oil applications, and different kinds of ice cubes to suck, as well as

Совпадение в полном тексте источника
… opioids | Patients with local cryotherapy presented a significant lower occurrence of grade 3-4 OM, compared with arm B (5.6% vs 44.4%, P = .0002), significant lower occurrence of all grades OM, IV opioids, and TPN administration | Unclear risk of bias (standard randomization process carried out by the biostatistics …

Brigatinib и Alectinib for ALK Restruction-Positive Under-Spective Meta-Analysis с центральной нервной системой или без нее.

На сегодняшний день ни одно из испытаний не сравнивало эффективность бригатиниба и алектиниба с анапластической лимфатической киназой (АЛК) реструктуризацией положительной (ALK-p), АЛК-инбитор-наив, передовым раком легких немалых клеток (NSCLC) с метастазом центральной нервной системы (CNS). Мы провели непрямое сопоставление между бригатинибом и алектинибом с использованием кризотиниба в качестве общего компаратора, используя байезскую модель с неинформационным предварительным распределением, и провели оценку неоднородности исследований между исследованиями. Основным конечным показателем эффек

Совпадение в полном тексте источника
… The analysis was performed using OpenBUGS 1.4.0 (MRC Biostatistics Unit, Cambridge Public Health Research Institute, Cambridge, UK), and STATA (ver. 14, StataCorp, College Station, TX, USA) was used to create graphics for the presentation of the results. 2.8. …

Emerging markers of cachexia predict survival in cancer patients.

BACKGROUND: Cachexia may occur in 40% of cancer patients, representing the major cause of death in more than 20% of them. The aim of this study was to investigate the role of leptin, ghrelin and obestatin as diagnostic and predictive markers of cachexia in oncologic patients. Their impact on patient survival was also evaluated. METHODS: 140 adults with different cancer diagnoses were recruited. Thirty healthy volunteers served as control. Serum ghrelin, obestatin and leptin were tested at baseline and after a follow-up period of 18 months. RESULTS: Ghrelin levels were significantly higher in

Совпадение в полном тексте источника
… He has participated in several national and international scientific congresses and courses focusing on epidemiology, biostatistics, physiology and pathophysiology of kidney diseases. …

Isatuximab, bortezomib, lenalidomide и dexamethason for multieloma: динамика негатива MRD в исследовании IMROZ.

Квадруплетная терапия с Isa-VRd (изатуксимаб, велкад [бортезомиб], релимид [леналидомид] и дексаметасон), за которой последовала Иса-Рд в ходе случайного этапа 3 исследования IMROZ, дала значительную возможность выжить без прогрессирования пациентам, имеющим право на трансплантацию с недавно диагностированным множественным миэломой (NDMM). В ходе первичного анализа большее число пациентов, прошедших лечение Isa-VRd/Isa-Rd, достигли минимальной остаточной негативности (MRD) и полной реакции (MRD-отрицательной реакции) в любой момент времени, чем пациенты, получающие VRd, за которыми следует Rd.

Innate [18F]Fluorodeoxyglucose PET bone networks of lung cancer patients predict survival.

PurposePrognostication of lung cancer patients remains challenging clinically. This study aims to address this problem by investigating the utility of bone glucose metabolism networks as a prognostic biomarker of lung cancer patients. The rationale for targeting bone metabolic networks specifically comes from the long-recognised role of bone in innate immunity and the recent appreciation of the key role bones play in regulating whole-body glucose metabolism.MethodsThis study is a retrospective analysis of data from the multi-centre trial ACRIN 6668 on non-small cell lung carcinoma (NSCLC). Con

Совпадение в полном тексте источника
… All data collection and management were conducted by the Biostatistics and Data Management Centre at ACRIN, using a built-in security feature that encrypts data. PET images were reconstructed using OSEM with 8 subsets and 2, 3, or 4 iterations and smoothing of 6-mm 3D Gaussian kernel [ 25 ]. …

Предсказательная и прогнозирующая значимость результатов лечения пациентов в Даратумумаб-Трейд Множественной миеломы.

ЦЕЛИ: Результаты, о которых сообщают пациенты (РО), включая физическую функцию, имеют прогнозируемый потенциал выживания, но остаются недостаточно изученными в миеломе (ММ). В этом исследовании оценивается прогнозируемая и прогнозируемая ценность ПРО для результатов лечения пациентов из числа ОМ на основе терапии на основе дратумумаба и оценивается физическая функция по сравнению с показателями результативности ЭСГ как потенциальный видоизменяющий эффект лечения. МЕТОДЫ: данные были обобщены на основе выборочных испытаний (MAIA, POLLUX, CASTOR), которые собирали данные о предварительной обрабо

Совпадение в полном тексте источника
… Analysis and interpretation of data (e.g., statistical analysis, biostatistics, and computational analysis): S.A.A., E.B., A.M.H., Z.A., H.O.A.‐S., M.H.S., Z.K., S.M.A., R.M., Y.B., R.A.M., G.K., M.J.S., K.H.A., and A.Y.A. …

Многострановое исследование базы данных для оценки результатов беременности и младенчества после возможного воздействия кладрибинных таблеток на матерей или отцов при лечении множественного склероза: методы исследования КЛЕО и обновление статуса.

СПРАВОЧНАЯ ИНФОРМАЦИЯ: Кладрибинные таблетки противопоставляются во время беременности; таким образом, данные о безопасности беременности, подверженной такому лечению, ограничены. СЛАР собирает и описывает результаты беременности в этой недостаточно изученной группе населения. ЦЕЛИ: Описание основных особенностей структуры исследования, проведенного в рамках программы < < ЯДЕР > > , включая источники данных и методологический подход, и представление обновленной информации о ходе работы. DESIGN: CLEAR представляет собой неинтервенционное, многобазовое, сравнительное когортное исслед

Совпадение в полном тексте источника
… Alexandra Lauer, Biostatistics, Merck Healthcare KGaA, Darmstadt, Germany. Xiaolei Zhou, RTI Health Solutions, Research Triangle Park, NC, USA. Alison Kawai, RTI Health Solutions, Research Triangle Park, NC, USA. Rachel Weinrib, RTI Health Solutions, Barcelona, Spain. …

Opportunistic CT for Prediction of Adverse Postoperative Events in Patients with Spinal Metastases.

The purpose of this study was to assess the value of body composition measures obtained from opportunistic abdominal computed tomography (CT) in order to predict hospital length of stay (LOS), 30-day postoperative complications, and reoperations in patients undergoing surgery for spinal metastases. 196 patients underwent CT of the abdomen within three months of surgery for spinal metastases. Automated body composition segmentation and quantifications of the cross-sectional areas (CSA) of abdominal visceral and subcutaneous adipose tissue and abdominal skeletal muscle was performed. From this,

Maintenance therapy for cytogenetically high-risk multiple myeloma: landscape in the era of novel drugs.

Although the significant strides in novel therapeutic approaches have prolonged the survival of multiple myeloma (MM) patients, the unfavorable prognosis of cytogenetically high-risk newly diagnosed MM (NDMM) remains intractable with the lack of consensus regarding the choice of maintenance regimens. Therefore, this study was initiated with the aim of examining the effectiveness of various maintenance treatments for this group of patients in jeopardy. Overall, 17 studies with 1937 high-risk NDMM patients were included in the network meta-analysis. Combination therapies involving novel drugs pr

Совпадение в полном тексте источника
… Markov chain Monte Carlo methods in biostatistics. Stat Methods Med Res. 1996;5(4):339–55. 20. Brooks SP, Gelman A. General methods for monitoring convergence of iterative simulations. J Comput Graph Stat. 1998;7(4):434–55. 21. Higgins JP, Thompson SG. …

Несмотря на современные методы лечения: ретроспективное исследование 99 больные лейкемией первичной и вторичной плазменной клеток.

Плазменная клеточная лейкемия (ПХЛ) является редкой моноклонной гаммопатией, связанной с коротким выживанием. Из-за весьма низкой распространенности этого заболевания было зарегистрировано лишь несколько групп, и, таким образом, информация об этом заболевании является скудной. Цель этого исследования состояла в том, чтобы лучше понять клинические особенности, прогнозируемые факторы и эффективность современных методов лечения как в первичном ПХЛ (ПХЛ), так и в вторичном ПХЛ (СПХЛ). МЕТОДЫ: Мы провели ретроспективное многоцентральное исследование пациентов с диагнозом ПХЛ, определяемого как цирк

Совпадение в полном тексте источника
… We would also like to acknowledge the help of the biostatistics consulting service of the CHUS, especially Mr. S. Lemaire‐Paquette, for their support with data analysis. Tessier C, LeBlanc R, Roy J, et al. …

Chemotherapy-based versus chemotherapy-free stem cell mobilization (± plerixafor) in multiple myeloma patients: an Italian cost-effectiveness analysis.

Given the availability and efficacy of the mobilizing agent plerixafor in augmenting hematopoietic progenitor cell mobilization with granulocyte colony-stimulating factor (G-CSF), there is a strong case for comparing the cost-effectiveness of mobilization with G-CSF + cyclophosphamide versus G-CSF alone. This study investigated the cost and effectiveness (i.e., successful 4 million-CD34+ collection) of G-CSF alone versus high-dose cyclophosphamide (4 g/m2) + G-CSF mobilization (± on-demand plerixafor) in patients with multiple myeloma (MM) eligible for autograft in Italy. A decision tree-suppo

Совпадение в полном тексте источника
… Pagano M, Gauvreau K Principles of biostatistics, 2nd edn Duxbury Press: Pacific Grove, USA, 2000. 49. Briggs AH, Gray AM. Handling uncertainty when performing economic evaluation of healthcare interventions. Health Technol Assess. 1999;3:1–134. doi: 10.3310/hta3020. 50. Black WC. …

Multiple myeloma: patient outcomes in real-world practice.

With increasing number of therapies available for the treatment of multiple myeloma, it is timely to examine the course of patients' journeys. We investigated patient characteristics, treatment durations and outcomes, and symptom burden across the treatment pathway in Belgium, France, Germany, Italy, Spain, Switzerland and the UK. In total, 435 physicians retrospectively reviewed 4997 patient charts. Profiles of patients diagnosed with multiple myeloma during the last 12 months were similar across countries; bone pain was the most common presentation. Median duration of first-line therapy was

Совпадение в полном тексте источника
… Berkeley Division of Biostatistics Working Paper Series. Working Paper 130. Vol. 2015. Lonial , S. & Anderson , K.C. ( 2014 ) Association of response endpoints with survival outcomes in multiple myeloma . …

Cancer prevalence in United States, Nordic Countries, Italy, Australia, and France: an analysis of geographic variability.

BackgroundThe objectives of this study were to quantitatively assess the geographic heterogeneity of cancer prevalence in selected Western Countries and to explore the associations between its determinants.MethodsFor 20 cancer sites, 5-year cancer prevalence, incidence, and survival were observed and age standardised for the mid 2000s in the United States, Nordic European Countries, Italy, Australia, and France.ResultsIn Italy, 5-year crude prevalence for all cancers was 1.9% in men and 1.7% in women, while it was ∼1.5% in all other countries and sexes. After adjustment for the different age d

Совпадение в полном тексте источника
… Web Appendix 3 Appendix Members of the AIRTUM working group Antonella Zucchetto (Epidemiology and Biostatistics Unit, Aviano); Adele Caldarella (Tuscany Cancer Registry); Emanuela Bovo (Registro Tumori Veneto); Giovanna Tagliabue (Registro Tumori Varese, Fondazione IRCCS, Istituto Nazionale dei Tumori …

Effect of electronic patient record use on mortality in End Stage Renal Disease, a model chronic disease: retrospective analysis of 9 years of prospectively collected data.

BackgroundIn chronic disease, health information technology promises but has yet to demonstrate improved outcomes and decreased costs. The main aim of the study was to determine the effects on mortality and cost of an electronic patient record used in daily patient care in a model chronic disease, End Stage Renal Disease, treated by chronic maintenance hemodialysis. Dialysis treatment is highly regulated, and near uniform in treatment modalities and drugs used.MethodsThe particular electronic patient record, patient-centered and extensively coded, was used first in patient care in 3 dialysis u

Совпадение в полном тексте источника
… Ralph Buncher, Sc.D., Department of Epidemiology and Biostatistics, University of Cincinnati, Julien I. E. Hoffman, M.D., Department of Pediatrics, University of California San Francisco, Morris J. Karnovsky, M.D., Department of Pathology, Harvard Medical School, and Robert W. …

Автологичная трансплантация стволовых клеток гематопоиета стабилизирует атрофию сетчатки в множестве склероза.

Автологическая трансплантация стволовых клеток гематопоиета — это эффективное лечение агрессивных множественных рефракторов склероза для лечения заболеваний. Тем не менее, его воздействие на нейродегенерацию по-прежнему недостаточно изучено, и существует мало прогнозов биомаркеров для клинических результатов после аутологической трансплантации гематопоэтических стволовых клеток. Мы изучили, смягчает ли аутологическая трансплантация стволовых клеток процесс нейродегенерации сетчатки и предвосхищают ли показатели оптической согласованности, полученные на основе сетчатки, развитие инвалидности по

Совпадение в полном тексте источника
… We thank Monika Hebeisen from the Epidemiology, Biostatistics and Prevention Institute at the University of Zurich for advice with the statistical analysis. The graphical abstract was created using BioRender: Zoellin, J. (2026) https://BioRender.com/9wz7859 . …

A data-driven model of disability progression in progressive multiple sclerosis.

This study applies the Gaussian process progression model, a Bayesian data-driven disease progression model, to analyse the evolution of primary progressive multiple sclerosis. Utilizing data from 1521 primary progressive multiple sclerosis participants collected within the International Progressive Multiple Sclerosis Alliance Project, the analysis includes 18 581 longitudinal time-points (average follow-up time: 28.2 months) of disability assessments including the expanded disability status scale, symbol digit modalities, timed 25-foot-walk, 9-hole-peg test and of MRI metrics such as T1 and T

A Triazaspirane Derivative Inhibits Migration and Invasion in PC3 Prostate Cancer Cells.

Cancer is a serious health problem due to the complexity of establishing an effective treatment. The purpose of this work was to evaluate the activity of a triazaspirane as a migration and invasion inhibitor in PC3 prostatic tumor cells through a possible negative regulation of the FAK/Src signal transduction pathway and decreased secretion of metalloproteinases 2 and 9. Molecular docking analysis was performed using Moe 2008.10 software. Migration (wound-healing assay) and invasion (Boyden chamber assay) assays were performed. In addition, the Western blot technique was used to quantify prote

Совпадение в полном тексте источника
… Fundamentals of Biostatistics. 6th ed. Thomson-Brooks/Cole; Belmont, CA, USA: 2006. Associated Data Supplementary Materials Click here for additional data file. Data Availability Statement The data obtained throughout the experiments can be provided by O. G-H. upon reasonable request. …

Body shape phenotypes of multiple anthropometric traits and cancer risk: a multi-national cohort study.

BackgroundClassical anthropometric traits may fail to fully represent the relationship of weight, adiposity, and height with cancer risk. We investigated the associations of body shape phenotypes with the risk of overall and site-specific cancers.MethodsWe derived four distinct body shape phenotypes from principal component (PC) analysis on height, weight, body mass index (BMI), waist (WC) and hip circumferences (HC), and waist-to-hip ratio (WHR). The study included 340,152 men and women from 9 European countries, aged mostly 35-65 years at recruitment (1990-2000) in the European Prospective I

Совпадение в полном тексте источника
… The coordination of EPIC is financially supported by the International Agency for Research on Cancer (IARC) and by the Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, which has additional infrastructure support provided by the NIHR Imperial Biomedical Research …

Показания пациентов с множественными миеломными пациентами, прошедшими курс лечения в соответствии со стандартом ухода Idecabtagen Vicleucel.

Idecabtagen vicleucel (ide-cel) был первым утвержденным УЛХ химериком антиген-рецептором Т-клектором для пациентов с множественным миэломой (RRMM). Это было первое исследование для оценки результатов, сообщаемых пациентами (ПИО) среди пациентов, получающих идицель в стандарте медицинского обслуживания (ЗСО). Перспективно оцениваемое качество жизни, связанное со здоровьем (HRQOL), и симптомы, связанные с предвыпуском (исходным уровнем) и днем (D)90 После вливания. Базовые ассоциации ПРО, имеющие характеристики пациентов, средние изменения ПРО и время для стабильных изменений оценивались с помощ

Совпадение в полном тексте источника
… Myers and Family Multiple Myeloma Fund, Moffitt Cancer Center’s Participant Research, Interventions, and Measurement (PRISM) Core and Biostatistics and Bioinformatics Shared Resource (BBSR), and a National Institutes of Health Cancer Center Support Grant (grant number P30CA076292). …